Roots Analysis Identifies 5 Leading AI-Based Digital Pathology Companies
Roots Analysis has identified five key AI-based digital pathology companies advancing disease diagnosis through enhanced imaging and analysis.
Research firm Roots Analysis released its list of the top five AI-based digital pathology companies in November 2023. The selections were based on a proprietary analysis of company competitiveness, considering portfolio strength and funding.
Digital pathology leverages artificial intelligence and machine learning to move beyond traditional microscopy. This approach allows for the digital scanning and analysis of tissue samples, accelerating the transmission and interpretation of results. The technology aids healthcare professionals in quantitative and qualitative assessment, helping to identify risks and tailor treatment paths.
The market for AI-based digital pathology solutions is projected for significant growth, according to Roots Analysis. This expansion is attributed to factors such as the accelerating digitalization of pathology, adoption of high-throughput scanning technologies, and the need to address shortages of skilled pathologists.
The research also highlights increased investor interest in the sector, which is expected to fuel innovation in digital imaging for diagnosing diseases, including cancer. The companies identified as leaders in this space include Akoya Biosciences, Ibex Medical Analytics, Paige, PathAI, and PROSCIA.
Roots Analysis has conducted an extensive study on the digital pathology market, covering its current landscape, funding trends, and future opportunities through 2035. The firm also analyzes AI's role in patient engagement, liquid biopsy, and remote patient monitoring solutions.